Odronextamab
RG1124641
Phase 2 mab active
Quick answer
Odronextamab for Recurrent Diffuse Large B-Cell Lymphoma is a Phase 2 program (mab) at Regeneron UK Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Regeneron UK Limited
- Indication
- Recurrent Diffuse Large B-Cell Lymphoma
- Phase
- Phase 2
- Modality
- mab
- Status
- active